Creative Medical Technology Holdings, Inc. (CELZ) Gross Margin
- Gross margin · 12 months: Value 66.87%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 66.87% | Gross profit / revenue. Period ending 2026-06-30. $2.01K ÷ $3.00K × 100 ≈ 66.87% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 2.01K USD | Gross Profit |
| Revenue | 3.00K USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $2.01K | $3.00K | (m) | 66.87% |
| 2026-03-31 | $2.01K | $3.00K | (m) | 66.87% |
| 2025-12-31 | $3.81K | $6.00K | (m) | 63.43% |
| 2025-09-30 | $3.60K | $6.00K | (m) | 60.00% |
| 2025-06-30 | $3.60K | $6.00K | (m) | 60.00% |
| 2025-03-31 | $8.40K | $14.00K | (m) | 60.00% |
| 2024-12-31 | $6.60K | $11.00K | (m) | 60.00% |
| 2024-09-30 | $6.60K | $11.00K | (m) | 60.00% |
| 2024-06-30 | $10.20K | $17.00K | (m) | 60.00% |
| 2024-03-31 | $5.40K | $9.00K | (m) | 60.00% |
| 2023-12-31 | $5.40K | $9.00K | (m) | 60.00% |
| 2023-09-30 | $16.50K | $24.60K | (m) | 67.07% |
| 2023-06-30 | $51.90K | $73.60K | (m) | 70.52% |
| 2023-03-31 | $51.90K | $73.60K | (m) | 70.52% |
| 2022-12-31 | $60.11K | $88.60K | (m) | 67.84% |
| 2022-09-30 | $75.51K | $137.75K | (m) | 54.82% |
| 2022-06-30 | $42.51K | $92.75K | (m) | 45.84% |
| 2022-03-31 | $48.01K | $102.75K | (m) | 46.73% |
| 2021-12-31 | $39.80K | $87.75K | (m) | 45.36% |
| 2021-09-30 | $21.00K | $37.50K | (m) | 56.00% |
| 2021-06-30 | $74.40K | $104.50K | (m) | 71.20% |
| 2021-03-31 | $86.00K | $122.40K | (m) | 70.26% |
| 2020-12-31 | $113.90K | $164.50K | (m) | 69.24% |
| 2020-09-30 | $95.94K | $142.60K | (m) | 67.28% |
| 2020-06-30 | $86.04K | $123.10K | (m) | 69.90% |
| 2020-03-31 | $111.34K | $156.80K | (m) | 71.01% |
| 2019-12-31 | $120.00K | $165.50K | (m) | 72.51% |
| 2019-09-30 | $157.01K | $227.50K | (m) | 69.01% |
| 2019-06-30 | $123.51K | $222.40K | (m) | 55.54% |
| 2019-03-31 | $83.39K | $165.60K | (m) | 50.35% |
| 2018-12-31 | $54.02K | $124.40K | (m) | 43.43% |
| 2018-09-30 | $22.28K | $71.60K | (m) | 31.11% |
| 2018-06-30 | $6.27K | $19.20K | (m) | 32.67% |
| 2018-03-31 | $4.00K | $14.40K | (m) | 27.78% |
| 2017-12-31 | $-3.20K | $4.80K | (m) | -66.67% |
| 2017-09-30 | (m) | $0.00 | (m) | (m) |
| 2017-06-30 | (m) | $0.00 | (m) | (m) |
| 2017-03-31 | (m) | $0.00 | (m) | (m) |
| 2016-12-31 | (m) | $0.00 | (m) | (m) |
| 2016-09-30 | (m) | $0.00 | (m) | (m) |
| 2016-06-30 | (m) | $0.00 | (m) | (m) |
| 2016-03-31 | (m) | $0.00 | (m) | (m) |
| 2015-12-31 | (m) | $0.00 | (m) | (m) |
| 2015-09-30 | (m) | $0.00 | (m) | (m) |
| 2015-06-30 | (m) | $0.00 | (m) | (m) |
| 2015-03-31 | (m) | $0.00 | (m) | (m) |
| 2014-12-31 | (m) | $0.00 | (m) | (m) |
| 2014-09-30 | (m) | $0.00 | (m) | (m) |
| 2014-06-30 | (m) | $0.00 | (m) | (m) |
| 2014-03-31 | (m) | $0.00 | (m) | (m) |
| 2013-12-31 | (m) | $0.00 | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $0.00 | (m) | (m) |
| 2012-09-30 | (m) | $0.00 | (m) | (m) |
| 2012-06-30 | (m) | $0.00 | (m) | (m) |
| 2012-03-31 | (m) | $0.00 | (m) | (m) |
| 2011-12-31 | (m) | $0.00 | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $0.00 | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |